Rafael Simó Canonge-rekin lankidetzan egindako argitalpenak (9)

2020

  1. Effect of topical administration of somatostatin on retinal inflammation and neurodegeneration in an experimental model of diabetes

    Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-18

2016

  1. Effects of the neuroprotective drugs somatostatin and brimonidine on retinal cell models of diabetic retinopathy

    Acta Diabetologica, Vol. 53, Núm. 6, pp. 957-964

  2. Modulation of microglia polarization dynamics during diabetic retinopathy in db/db mice

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1862, Núm. 9, pp. 1663-1674

  3. Somatostatin protects photoreceptor cells against high glucose–induced apoptosis

    Molecular Vision, Vol. 22, pp. 1522-1531

  4. Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes

    Diabetes, Vol. 65, Núm. 1, pp. 172-187

2014

  1. Glycogen storage in the human retinal pigment epithelium: A comparative study of diabetic and non-diabetic donors

    Acta Diabetologica, Vol. 51, Núm. 4, pp. 543-552

2013

  1. Proapoptotic and survival signaling in the neuroretina at early stages of diabetic retinopathy

    Molecular Vision, Vol. 19, pp. 47-53

  2. Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes

    Diabetes, Vol. 62, Núm. 7, pp. 2569-2578

2012

  1. Beneficial effects of fenofibrate in retinal pigment epithelium by the modulation of stress and survival signaling under diabetic conditions

    Journal of Cellular Physiology, Vol. 227, Núm. 6, pp. 2352-2362